Geneos Wealth Management’s ZimVie ZIMV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-57
| Closed | -$1.08K | – | 2573 |
|
|
2025
Q3 | $1.08K | Hold |
57
| – | – | ﹤0.01% | 2399 |
|
|
2025
Q2 | $533 | Sell |
57
-94
| -62% | -$858 | ﹤0.01% | 3103 |
|
|
2025
Q1 | $1.63K | Buy |
151
+102
| +208% | +$1.34K | ﹤0.01% | 3001 |
|
|
2024
Q4 | $684 | Sell |
49
-3
| -6% | -$43 | ﹤0.01% | 2844 |
|
|
2024
Q3 | $825 | Hold |
52
| – | – | ﹤0.01% | 2480 |
|
|
2024
Q2 | $949 | Hold |
52
| – | – | ﹤0.01% | 1987 |
|
|
2024
Q1 | $857 | Hold |
52
| – | – | ﹤0.01% | 2057 |
|
|
2023
Q4 | $923 | Buy |
+52
| New | +$524 | ﹤0.01% | 2024 |
|
|
2023
Q3 | – | Sell |
-52
| Closed | -$584 | – | 2149 |
|
|
2023
Q2 | $584 | Buy |
+52
| New | +$505 | ﹤0.01% | 2057 |
|
|
2022
Q4 | – | Sell |
-52
| Closed | – | – | 2107 |
|
|
2022
Q3 | $0 | Sell |
52
-74
| -59% | -$1.19K | ﹤0.01% | 2625 |
|
|
2022
Q2 | $2K | Sell |
126
-6
| -5% | -$132 | ﹤0.01% | 2440 |
|
|
2022
Q1 | $3K | Buy |
+132
| New | +$3.11K | ﹤0.01% | 2502 |
|
Other funds holding ZIMV
Geneos Wealth Management's ZIMV Position: Q4 2025 in Review
Geneos Wealth Management sold out of ZimVie (ZIMV) in Q4 2025, closing a stake of 57 shares — an estimated $1.08K sold.
Geneos Wealth Management first reported a position in ZIMV in Q1 2022 and held it in 12 quarters. The position peaked at $3K in Q1 2022. 1 fund tracked by Wall St. Rank holds ZIMV as of Q4 2025.
- Geneos Wealth Management reported no remaining ZimVie position as of Q4 2025 after selling out during the quarter.
- Geneos Wealth Management sold 57 ZimVie shares in Q4 2025, an estimated $1.08K.
- Geneos Wealth Management first reported a position in ZimVie in Q1 2022 and held it in 12 quarters.
- Geneos Wealth Management's ZimVie position peaked at $3K in Q1 2022.
- 1 fund tracked by Wall St. Rank held ZimVie as of Q4 2025.
Based on Geneos Wealth Management's 13F filing for Q4 2025, filed 28 Jan 2026.